Autopsy report · NCT06644079

Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma

“Study not moving forward due to upcoming PI departure”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Florida

Sponsor type

University, hospital or other

Conditions

Cutaneous Squamous Cell Carcinoma

Interventions

Tranexamic acid

Participants

0

Trials that died the same way

• Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
  “PI does not have time to continue study” (77% match in meaning)
• Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples
  “no PI to continue the study” (73% match in meaning)
• Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer
  “Pi departure; service discontinued study” (73% match in meaning)
• Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
  “Staffing disruptions leading to incomplete study enrollment prior to PI departure.” (72% match in meaning)
• Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery
  “Study never started. PI is leaving institution.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.